Activist investor Starboard Value takes $1 billion stake in Pfizer, sources say
Activist investor Starboard Value has taken a stake of about $1 billion in Pfizer and wants the U.S. drug giant to make ...
Low RSV and COVID vaccine usage is in line with investor expectations, but concerning: Jefferies
Low uptake in the RSV and COVID vaccine markets is not surprising, an analyst says, and could mean weak earnings for ...
Pfizer shares jump on $1 bln activist investor stake
STORY: Shares of Pfizer rose as much as four percent in Monday morning trading after activist investor Starboard Value took ...
STAT3d
After a rocky debut for new RSV tools, hopes are high as a new season approaches
Spread of the virus is seasonal, with activity often picking up in the fall after kids go back to school. Activity usually ...
Making an RSV Vaccine Was Hard. Getting People to Take It Is Even Harder
RSV hospitalizes thousands of people in the US every year. Three new vaccines could help stem the spread, but there are ...
FiercePharma12h
Dupixent takes pharma DTC top spot as Pfizer's COVID drug Paxlovid makes a comeback
AbbVie’s immunology duo Skyrizi and Rinvoq is, in a rare blip this year, not leading the pharma DTC monthly rankings as ...
The American Journal of Managed Care12d
RSV Vaccines Effective in Older Adults in Long-Term Care Facilities
This study aimed to assess the short-term immune response of an RSV vaccine in a population of older adults 60 years and ...
EconoTimes1d
Activist Investor Starboard Value Takes $1B Stake in Pfizer, Calls for Strategic Overhaul
Activist investor Starboard Value has acquired a $1 billion stake in Pfizer to push for strategic changes in the U.S.
Activist investor Starboard Value takes $1 bln stake in Pfizer, sources say
Activist investor Starboard Value has taken a stake of about $1 billion in Pfizer and wants the U.S. drug giant to make ...